Valley Behavioral Health Masters Program

Type of Care

Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

Outpatient

Pharmacotherapies

Fluphenazine Haloperidol Aripiprazole Brexpiprazole Cariprazine Clozapine IIoperidone Lurasidone Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Non-nicotine smoking/tobacco cessation Antipsychotics used in treatment of SMI

Treatment Approaches

Cognitive behavioral therapy Dialectical behavior therapy Group therapy Individual psychotherapy Telemedicine/telehealth therapy

Facility Operation (e.g., Private, Public)

Private non-profit organization

Payment/Insurance/Funding Accepted

County or local government funds Medicare Medicaid Private health insurance Cash or self-payment State mental health agency (or equivalent) funds

Special Programs/Groups Offered

Seniors or older adults Veterans Members of military families Clients with co-occurring mental and substance use disorders Clients with HIV or AIDS Clients who have experienced trauma Persons with eating disorders Persons with post-traumatic stress disorder (PTSD) Persons 18 and older with serious mental illness (SMI)

Assessment/Pre-treatment

Screening for tobacco use

Testing

Laboratory testing

Recovery Support Services

Housing services Mentoring/peer support

Education and Counseling Services

Smoking/vaping/tobacco cessation counseling

Facility Smoking Policy

Smoking permitted in designated area

Age Groups Accepted

Seniors

Facility Vaping Policy

Vaping permitted in designated area

Ancillary Services

Case management service